Rational design of potent GSK3β inhibitors with selectivity for Cdk1 and Cdk2

被引：24
|
作者：
Lesuisse, Dominique [1 ,5 ]
Dutruc-Rosset, Gilles [1 ,5 ]
Tiraboschi, Gilles [3 ,5 ]
Dreyer, Matthias K. [6 ]
Maignan, Sebastien [4 ,5 ]
Chevalier, Alain [1 ,5 ]
Halley, Frank [1 ,5 ]
Bertrand, Philippe [2 ,5 ]
Burgevin, Marie-Claude [2 ,5 ]
Quarteronet, Dominique [2 ,5 ]
Rooney, Thomas [2 ,5 ]
机构：
[1] Med Chem, F-94300 Vitry Sur Seine, France
[2] CNS Dept, F-94300 Vitry Sur Seine, France
[3] CAS Mol Modelling, F-94300 Vitry Sur Seine, France
[4] CAS Struct Biol, F-94300 Vitry Sur Seine, France
[5] Sanofi Aventis, F-94300 Vitry Sur Seine, France
[6] Sanofi Aventis, D-65926 Frankfurt, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 06期
关键词：
Glycogen synthase kinase; GSK3; beta; Aminoindazole; Cdk's; SYNTHASE KINASE-3 GSK-3; CRYSTAL-STRUCTURE; PROTEIN;
D O I：
10.1016/j.bmcl.2010.01.114
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
From an HTS hit, a series of potent and selective inhibitors of GSK3 beta have been designed based on a Cdk2-homology model and with the help of several crystal structures of the compounds within Cdk2. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1985 / 1989
页数：5
相关论文
共 50 条
  • [41] 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors
    Singh, Sanjeev Kumar
    Dessalew, Nigus
    Bharatam, Prasad V.
    MEDICINAL CHEMISTRY, 2007, 3 (01) : 75 - 84
  • [42] Novel optimization of valmerins (tetrahydropyrido[1,2-a] isoindolones) as potent dual CDK5/GSK3 inhibitors
    Ouach, Aziz
    Boulahjar, Rajaa
    Vala, Christine
    Bourg, Stephane
    Bonnet, Pascal
    Guguen-Guillouzo, Christiane
    Ravache, Myriam
    Le Guevel, Remy
    Lozach, Olivier
    Lazar, Said
    Troin, Yves
    Meijer, Laurent
    Ruchaud, Sandrine
    Akssira, Mohamed
    Guillaumet, Gerald
    Routier, Sylvain
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 : 311 - 325
  • [43] Searching for potent CDK2 inhibitors using a variant of the Cope elimination
    Henderson, A
    Cheng, YZ
    Curtin, NJ
    Endicott, JA
    Golding, BT
    Griffin, RJ
    Hardcastle, IR
    Newell, DR
    Noble, MEM
    Wang, LZ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2725 - U2726
  • [44] Yeast as a model system to screen purine derivatives against human CDK1 and CDK2 kinases
    Mayi, Therese
    Facca, Celine
    Anne, Sandrine
    Vernis, Laurence
    Huang, Meng-Er
    Legraverend, Michel
    Faye, Gerard
    JOURNAL OF BIOTECHNOLOGY, 2015, 195 : 30 - 36
  • [45] Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle
    Golsteyn, RM
    CANCER LETTERS, 2005, 217 (02) : 129 - 138
  • [46] Yeast as a model system to screen purine derivatives against human CDK1 and CDK2 kinases
    Mayi, T.
    Huang, M. E.
    Vernis, L.
    Legraverend, M.
    Faye, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S80 - S80
  • [47] Structural basis of valmerins as dual inhibitors of GSK3β/CDK5
    Li, Xiaolong
    Wang, Xiaowei
    Tian, Zibin
    Zhao, Houling
    Liang, Da
    Li, Weisong
    Qiu, Yujin
    Lu, Shaoyong
    JOURNAL OF MOLECULAR MODELING, 2014, 20 (09) : 1 - 11
  • [48] Structural basis of valmerins as dual inhibitors of GSK3β/CDK5
    Xiaolong Li
    Xiaowei Wang
    Zibin Tian
    Houling Zhao
    Da Liang
    Weisong Li
    Yujin Qiu
    Shaoyong Lu
    Journal of Molecular Modeling, 2014, 20
  • [49] Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer
    Kim, S. J.
    Nakayama, S.
    Miyoshi, Y.
    Taguchi, T.
    Tamaki, Y.
    Matsushima, T.
    Torikoshi, Y.
    Tanaka, S.
    Yoshida, T.
    Ishihara, H.
    Noguchi, S.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 68 - 72
  • [50] Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1
    Santaguida, M
    Nepveu, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (38) : 32712 - 32721
12345